Mission: To be one of the most innovative healthcare companies in the world where passionate people deliver breakthrough evidence-based therapies that transform patient lives.
Nevro is committed to improving outcomes in Chronic Pain and people are taking notice! We are excited to share that the publication of our 24-month RCT outcomes earned Top Pain Paper of the Year from the prestigious journal - Neurosurgery.
Our leader Rami Elghandour and CFO Andrew Galligan share Nevro's positive outlook at the Morgan Stanley 2017 Global Healthcare Conference
Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS).
We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
“All qualified applicants will receive consideration for employmentwithout regard to race, sex, color, religion, sexual orientation, gender identity,national origin, protected veteran status, or on the basis of disability.”
Learn how Nevro is impacting patients’ lives
Learn more about Nevro
RAMI ELGHANDOUR — PRESIDENT AND CEO
Rami Elghandour joined Nevro in 2012, has served as Nevro’s Chief Business Officer, and currently serves as President and CEO of the company. Prior to joining Nevro, Mr. Elghandour was an investor with Johnson & Johnson Development Corporation (JJDC), where he led several investments including Nevro Series B Financing. During his tenure, Mr. Elghandour served on the Board of Directors of several private companies, including Nevro’s, and led strategic initiatives in the development and management of JJDC’s portfolio. Prior to joining JJDC, Mr. Elghandour worked for Advanced Neuromodulation Systems, Inc. (acquired by St. Jude Medical, Inc.), where he led firmware design and development on several implantable spinal cord stimulators. Mr. Elghandour received a MBA from the Wharton School of the University of Pennsylvania and holds a BS in Electrical and Computer Engineering from Rutgers University School of Engineering.
ANDREW GALLIGAN — CHIEF FINANCIAL OFFICER
Andrew Galligan joined Nevro in 2010 and is Vice President of Finance and Chief Financial Officer of the Company. Prior to joining Nevro, Mr. Galligan held the same position at OOMA, a consumer electronics manufacturer and VOIP service provider. Prior to that, Mr. Galligan was Vice President Finance and Chief Financial Officer of Reliant Technologies, a pioneer of fractional resurfacing skin treatments with aesthetic lasers. Mr. Galligan has also held the top financial executive position at several other medical device companies bringing to Nevro many years of experience in the commercialization of innovative medical therapeutic and diagnostic technologies. Mr. Galligan began his career in various financial positions at KPMG, and Raychem. Mr. Galligan received his degree in Business Studies from Trinity College in Dublin, Ireland, and he is also a Fellow of the Institute of Chartered Accountants in Ireland.
DAVID CARAWAY, MD, PHD — CHIEF MEDICAL OFFICER
David Caraway, MD, PhD joined Nevro in 2014 and serves as Nevro’s Chief Medical Officer. Prior to joining Nevro, Dr. Caraway was the CEO of The Center for Pain Relief, Tri-State, L.L.C., in partnership with St. Mary’s Regional Medical Center in Huntington, West Virginia. Dr. Caraway has maintained an active medical practice for over 20 years and has held leadership positions in the North American Neuromodulation and the American Society of Interventional Pain Physicians. As a nationally recognized expert in the treatment of chronic pain, he has lectured regionally, nationally, and internationally in the field of Interventional Pain Medicine and authored numerous publications in this field. Dr. Caraway received a BS in Chemical Engineering from the University of Virginia School of Engineering, an MD from the University of Virginia School of Medicine, and a PhD in Biophysics from the University of Virginia Graduate School of Arts and Sciences. He also received post-graduate training in Anesthesiology and Pain Management from the University of Virginia. Dr. Caraway is board certified by the American Board of Anesthesiology.
DOUG ALLEAVITCH — VICE PRESIDENT, QUALITY
Doug Alleavitch joined Nevro in 2015 and serves as Vice President, Quality of the company. Prior to joining the Company and since October 2009, Mr. Alleavitch served as Vice President, Operations and Quality Assurance at AEGEA Medical, Inc., a medical device company, where he oversaw manufacturing and quality assurance procedures. From February 2002-09, he held leadership positions at AngioScore, Inc., and Boston Scientific. Mr. Alleavitch received a BS in Chemical Engineering from Cornell University, an MS in Industrial Engineering, and an MBA from the University of Illinois, and an MS in Chemical Engineering from the Illinois Institute of Technology.
RICHARD B. CARTER — VICE PRESIDENT, FINANCE, CORPORATE CONTROLLER
Richard B. Carter joined Nevro in 2014 and serves as Vice President of Finance, Corporate Controller of the company. He has held roles of increasing responsibility in finance and accounting since joining Nevro as Corporate Controller in September 2014. From October 2013-14, Mr. Carter served as Corporate Controller at ClearEdge Power, Inc., a privately held fuel cell manufacturing company. Previously, Mr. Carter held financial leadership roles at Kovio, MiaSolé, PortalPlayer, and Transmeta Corporation. Mr. Carter received a B.S. in Business Administration from California State University, Chico. Mr. Carter is a Certified Public Accountant and began his career as an auditor at Ernst & Young, LLP.
CHRISTOFER CHRISTOFOROU — VICE PRESIDENT, RESEARCH AND DEVELOPMENT
Christofer Christoforou joined Nevro in 2016 and serves as Vice President, R&D. Prior to joining Nevro, Mr. Christoforou served as Vice President, Quality Engineering at Thoratec Corporation, a medical device company where he oversaw the operational, design and supplier quality engineering functions. From October 1999-14, Mr. Christoforou served in several leadership positions of increasing levels of responsibility at Thoratec Corporation. From April 1993-99, Mr. Christoforou served as a Manager of Engineering and various Engineering positions for United States Surgical Corporation, a producer of tools for use in surgery. Mr. Christoforou received a BS in Biomedical Engineering from Boston University and a MS in Biomedical Engineering from Johns Hopkins University in Maryland.
DIVYA GHATAK — VICE PRESIDENT, HUMAN RESOURCES
Divya Ghatak joined Nevro in 2017 and serves as Vice President, Human Resources. Prior to joining Nevro, Ms. Ghatak served as Chief People Officer at GoodData, a data products and business intelligence company, where she led Global People Operations. Prior to GoodData, Ms. Ghatak held leadership roles at Cisco Systems from 2007-13 and at Tavant Technologies from 2004-07. From 1999-04, Ms. Ghatak founded her own executive search firm. Ms. Ghatak received a BA in Economics from Delhi University and an MA in Human Resources from Tata Institute of Social Sciences in Mumbai, India.
BRADFORD E. GLINER — VICE PRESIDENT, CLINICAL AND REGULATORY AFFAIRS
Bradford E. Gliner joined Nevro in 2011 and serves as Vice President of Clinical and Regulatory Affairs of the company. From 2008-11, Mr. Gliner was President and CEO at MitoGuard Neuroscience, Inc., a photobiomodulation medical device company. From 1999-08, Mr. Gliner was Vice President of Research at Northstar Neuroscience, Inc., a medical device company, where he led research on numerous neuromodulation applications. From 1992-99, Mr. Gliner was also a co-founder of Heartstream, Inc. (acquired by Koninklijke Philips Electronics NV), a medical device company that manufactures and markets automatic external defibrillators. Mr. Gliner received a BS in Electrical Engineering from the University of Illinois and an MS in Biomedical Engineering from Johns Hopkins University in Maryland.
MICHAEL HALL — GENERAL COUNSEL
Michael Hall joined Nevro in 2015 and is the General Counsel of the company. Mr. Hall was a partner of Latham & Watkins for 16 years prior to joining Nevro, and practiced for a number of years at Wilson, Sonsini, Goodrich & Rosati, and was a co-founder of Venture Law Group before joining Latham & Watkins. His practice was focused on representation of life science companies primarily in the medical device industry. He also represented underwriters and venture capital firms in both public and private financing transactions. He is a member of the board of San Francisco RBI, a non-profit focused on sports and literacy for underprivileged children in San Francisco. Mr. Hall received his BA from Sonoma State University and his JD degree from the University of California at Berkeley, School of Law (Boalt Hall).
PATRICK SCHMITZ — VICE PRESIDENT, OPERATIONS
Patrick Schmitz joined Nevro in 2016 and serves as Vice President, Operations. Prior to joining Nevro and since July 2005, Mr. Schmitz served as Vice President, Operations at Thoratec Corporation, a medical device company where he oversaw all domestic and international operations. From March 2003-05, Mr. Schmitz served as Vice President, North American Operations at GN ReSound, a medical device company. Mr. Schmitz also held several leadership positions in increasing levels of responsibility at St. Jude from March 1993-03. Mr. Schmitz holds a BS in Industrial Technology from the University of Wisconsin – Stout.
NEERAJ TEOTIA — VICE PRESIDENT, MARKETING
Neeraj Teotia joined Nevro in 2014, and serves as Vice President of Marketing. He has held roles of increasing responsibility in marketing since joining Nevro as Director, Marketing. Prior to joining Nevro, Mr. Teotia served as a Director, New Business Development in the Global Surgery Group at Johnson & Johnson where he was responsible for assessing various licensing and acquisition opportunities. Prior to his role in New Business Development, Mr. Teotia worked in various Marketing, Licensing & Acquisitions and Research & Development roles within the medical device group at Johnson & Johnson. Mr. Teotia received a MBA from the Kellogg School of Management at Northwestern University and holds a BS in Electrical Engineering from the University of Illinois at Urbana-Champaign.
I have been working at Nevro full-time (More than 8 years)
Team: Nevro continues to hire people who are committed to helping move the company forward.
Cross-functional approach: We accomplish more by soliciting ideas across the board. We divide the workload, we are agile, and we trust each other.
Culture: We are a growing company and we maintain the core identity of our culture as we scale the company while redefining the messaging as necessary.
As we are growing, we also need to have space to spread out. Management is addressing this but things are tight at the moment. Looking forward to our new space.
Advice to Management
Continue to allow people to be passionate. Creativity exists on all teams - even the teams where the processes can be tedious. Continue to listen to the small voices and allow people to define their roles.
I applied online. The process took 2 weeks. I interviewed at Nevro.
My interviewing process consisted of several phone interviews with different members of the department and management. Overall it was very casual and focused more on my background and what the internship would entail, and less on difficult or tricky questions. Very straightforward and enjoyable experience.
Let us know if we're missing any workplace or industry recognition –